Leveraging monoclonal antibodies as therapeutics to address antimicrobial resistance in bacteria
Vaishali Verma
DOI: 10.7324/jabb.2023.90087Pages: 53-60
Technological advancement in the development of monoclonal antibody therapies: Present, past, and future
Harit Kasana, Harish Chander, Ashwani Mathur
DOI: 10.7324/jabb.2024.172190Pages: 29-41
Molecular dynamics simulation of engineered Fc-FcγRIIIa complexes as a framework for anticancer monoclonal antibody development
Jebamani Petrina, Nitin Lingayat, Murugan Mukilan, Ravi Aiswarya Krishna, Dhamodharan Prabhu
DOI: 10.7324/JABB.2026.326155Pages:
